COVID-19: Progression of disease and intravascular coagulation - present status and future perspectives

Job Harenberg, Emmanuel Favaloro

Research output: Contribution to journalReview articlepeer-review

46 Citations (Scopus)

Abstract

The timely and accurate diagnosis of infection with severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), remains the cornerstone of efforts to provide appropriated treatment for patients, to limit further spread of the virus and ultimately to eliminate the virus from the human society. We focus this article on (a) developments for improvement of diagnosis of specific SARS-CoV-2 virus, (b) laboratory changes in the immunologic and coagulation system, (c) therapeutic options for anticoagulant treatment of seriously affected patients and (d) on the perspectives through improvement of diagnostic and therapeutic medical procedures.

Original languageEnglish
Pages (from-to)1029-1036
Number of pages8
JournalClinical Chemistry and Laboratory Medicine
Volume58
Issue number7
Early online date14 May 2020
DOIs
Publication statusPublished - 25 Jun 2020

Fingerprint

Dive into the research topics of 'COVID-19: Progression of disease and intravascular coagulation - present status and future perspectives'. Together they form a unique fingerprint.

Cite this